(Q36577209)

15 August 2017

1 reference

title

Autoimmune channelopathies (English)

1 reference

15 August 2017

2

Angela Vincent

1 reference

15 August 2017

Camilla Buckley

1

1 reference

15 August 2017

1 November 2005

1 reference

Nature Clinical Practice Neurology

15 August 2017

1 reference

15 August 2017

1

1 reference

15 August 2017

1

1 reference

15 August 2017

22-33

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

15 August 2017

1 reference

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Unravelling the pathogenesis of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Evidence of underdiagnosis of myasthenia gravis in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Passive transfer of autoimmune autonomic neuropathy to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Rasmussen's syndrome: progressive autoimmune multi-focal encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Cognition and immunity; antibody impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Lambert-Eaton Myasthenic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Phenotypic variants of autoimmune peripheral nerve hyperexcitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Morvan's syndrome associated with voltage-gated K+ channel antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Clinical analysis of anti-Ma2-associated encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Voltage‐gated potassium channel antibodies in limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Potassium channel antibodies in two patients with reversible limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Amnesia, cerebral atrophy, and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Deletion of the K(V)1.1 potassium channel causes epilepsy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Clinical evaluation and management of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999–2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Myasthenia Gravis: Passive Transfer from Man to Mouse

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Autoimmune Response to Acetylcholine Receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Myasthenia gravis and myasthenic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

The spectrum of autoimmune autonomic neuropathies

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

The Lambert-Eaton myasthenic syndrome. A review of 50 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Serum antibodies in epilepsy and seizure-associated disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Neurological disorders caused by inherited ion-channel mutations

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0033

7 January 2021

Identifiers

DOI

10.1038/NCPNEURO0033

1 reference

15 August 2017

1 reference

PubMed ID

16932489